https://www.ttci-th.org/wp-content/uploads/2024/06/video1504702293.mp4
Image: www.istockphoto.com A Phase 1 clinical trial to evaluate the safety and early efficacy of CAR T-cell with IL-7Ra signal targeting B7H3 in children with diffuse intrinsic pontine glioma...
Image: www.istockphoto.com Research Topics Development of immunotherapy for lung cancer treatment Researchers Aussara Panya, Yupanun Wutti-in, Sahutchai Inwongwan, Yingmanee Tragoolpua, Thida Kaewkod, Pachara Sattayawat, Chutipa Chiawpanit, Saruda Thongyim, Sitthisak...
CD99, which is highly expressed in T-acute lymphoblastic leukemia (T-ALL), could be an effective target for antibody-based treatment. In this study, researchers used a monoclonal antibody against CD99 called...
Scientists have developed a new and improved chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma, a type of blood cancer. 1 This new therapy uses a third-generation CAR...
Scientists Develop More Powerful Cancer-Fighting CellsScientists have created a new type of immune cell, called a CAR-T cell, that’s even better at fighting multiple myeloma, a type of blood...
Scientists Develop More Powerful Cancer-Fighting CellsScientists have created a new type of immune cell, called a CAR-T cell, that’s even better at fighting multiple myeloma, a type of blood...
Scientists are developing a new type of immunotherapy for cancer treatment called Tri-specific killer engagers (TriKEs). TriKEs are designed to activate natural killer (NK) cells, which are a type...
Exciting Breakthrough in CAR-T Cell Therapy Offers New Hope for Solid Tumor Treatment. In a groundbreaking study that could revolutionize cancer treatment, researchers have unveiled a new CAR-T cell...